These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34046360)

  • 1. Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population.
    Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
    Front Oncol; 2021; 11():670723. PubMed ID: 34046360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population.
    Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Xu B
    BMC Cancer; 2021 Dec; 21(1):1330. PubMed ID: 34906122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.
    Zhao HY; Gong Y; Ye FG; Ling H; Hu X
    Cancer Manag Res; 2018; 10():5937-5950. PubMed ID: 30538544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China.
    Li Y; Li Q; Mo H; Guan X; Lin S; Wang Z; Chen Y; Zhang Y; Zhang D; Chen S; Cai R; Wang J; Luo Y; Fan Y; Yuan P; Zhang P; Li Q; Ma F; Xu B
    Breast; 2021 Feb; 55():30-36. PubMed ID: 33310633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study.
    Xiao W; Zheng S; Liu P; Zou Y; Xie X; Yu P; Tang H; Xie X
    Cancer Med; 2018 Mar; 7(3):922-930. PubMed ID: 29473333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
    Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
    Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital.
    Cheng HF; Tsai YF; Huang CC; Lien PJ; Wang YL; Hsu CY; Chen YJ; Liu CY; Chao TC; Lin YS; Feng CJ; Chiu JH; Chau GY; Tseng LM
    J Chin Med Assoc; 2022 Jan; 85(1):88-94. PubMed ID: 34561409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different risk and prognostic factors for liver metastasis of breast cancer patients with
    Zhang N; Xiang Y; Shao Q; Wu J; Liu Y; Long H; Tao D; Zeng X
    Front Oncol; 2023; 13():1102853. PubMed ID: 37124528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
    Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
    Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
    Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
    JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Population-Based Study on Liver Metastases in Women with Newly Diagnosed Breast Cancer.
    Xie J; Xu Z
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):283-292. PubMed ID: 30487134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor conversion and survival in breast cancer liver metastases.
    Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
    Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC
    Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis.
    Kuksis M; Gao Y; Tran W; Hoey C; Kiss A; Komorowski AS; Dhaliwal AJ; Sahgal A; Das S; Chan KK; Jerzak KJ
    Neuro Oncol; 2021 Jun; 23(6):894-904. PubMed ID: 33367836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study.
    Xiao W; Zheng S; Yang A; Zhang X; Zou Y; Tang H; Xie X
    Cancer Manag Res; 2018; 10():5329-5338. PubMed ID: 30464629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
    Darlix A; Louvel G; Fraisse J; Jacot W; Brain E; Debled M; Mouret-Reynier MA; Goncalves A; Dalenc F; Delaloge S; Campone M; Augereau P; Ferrero JM; Levy C; Fumet JD; Lecouillard I; Cottu P; Petit T; Uwer L; Jouannaud C; Leheurteur M; Dieras V; Robain M; Chevrot M; Pasquier D; Bachelot T
    Br J Cancer; 2019 Dec; 121(12):991-1000. PubMed ID: 31719684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
    Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
    Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.